Data / Drug companies / Amlodipine besylate
Amlodipine besylate: 49 companies and 194 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amlodipine besylate is listed in the FDA National Drug Code Directory by 49 companies, with 194 products in commercial distribution. 184 of the products (94.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on October 1, 2026.
The request: Get every company that lists amlodipine besylate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 49
- Products
- 194
- Generic (ANDA) products
- 184 (94.8%)
- Application numbers
- 15
- Routes
- Oral
- Brand names
- Norvasc
- openFDA record search
- api.fda.gov
Companies that list amlodipine besylate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | 16 | tablet | Generic drugs (ANDA) | June 22, 2023 |
| A-S Medication Solutions | 14 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| Bryant Ranch Prepack | 11 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| Preferred Pharmaceuticals Inc. | 8 | tablet | Generic drugs (ANDA) | February 26, 2026 |
| Remedyrepack Inc. | 8 | tablet | Generic drugs (ANDA) | April 24, 2026 |
| NuCare Pharmaceuticals,Inc. | 7 | tablet | Generic drugs (ANDA) | October 1, 2021 |
| Ascend Laboratories, LLC | 6 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| Cipla USA Inc. | 6 | tablet | Generic drugs (ANDA) | July 1, 2016 |
| Exelan Pharmaceuticals Inc. | 6 | tablet | Generic drugs (ANDA) | March 15, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | October 1, 2021 |
| Proficient Rx LP | 5 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| American Health Packaging | 4 | tablet | Generic drugs (ANDA) | October 1, 2026 |
| Direct_Rx | 4 | tablet | Generic drugs (ANDA) | September 23, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 4 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | November 30, 2023 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | May 22, 2019 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | July 17, 2007 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | June 22, 2023 |
| Cardinal Health 107, LLC | 3 | tablet | Generic drugs (ANDA) | January 20, 2013 |
| China Resources Saike Pharmaceutical Co., Ltd. | 3 | tablet | Generic drugs (ANDA) | May 16, 2016 |
| Epic Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | April 25, 2011 |
| Legacy Pharmaceutical Packaging, LLC | 3 | tablet | Generic drugs (ANDA) | July 1, 2016 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | June 12, 2024 |
| Major Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | January 20, 2013 |
| Mylan Pharmaceuticals Inc. | 3 | tablet | Authorized generics (NDA) | June 24, 2019 |
| Oxford Pharmaceuticals, LLC | 3 | tablet | Generic drugs (ANDA) | October 1, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 20, 2010 |
| Pfizer Laboratories Div Pfizer Inc | 3 | tablet | New drug applications (NDA) | July 31, 1992 |
| Quallent Pharmaceuticals Health LLC | 3 | tablet | Generic drugs (ANDA) | December 1, 2022 |
| Redpharm Drug | 3 | tablet | Generic drugs (ANDA) | May 22, 2019 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | July 20, 2026 |
| Safecor Health, LLC | 3 | tablet | Generic drugs (ANDA) | June 1, 2026 |
| Teva Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 1, 2022 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet | Generic drugs (ANDA) | May 22, 2019 |
| Viatris Specialty LLC | 3 | tablet | New drug applications (NDA) | November 12, 2024 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | September 21, 2007 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | September 21, 2007 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | November 2, 2007 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | September 8, 2026 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | May 23, 2007 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | October 20, 2010 |
| QPharma, Inc. | 2 | tablet | Generic drugs (ANDA) | December 6, 2025 |
| Unit Dose Solutions, Inc. | 2 | tablet | Generic drugs (ANDA) | June 16, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | November 2, 2007 |
| Boswell Pharmacy Services LLC D/B/A BPS Wholesale | 1 | tablet | Generic drugs (ANDA) | October 21, 2025 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | December 12, 2023 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | August 11, 2017 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | July 20, 2023 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | October 15, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 194 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 184 | 94.8% |
| New drug applications (NDA) | 6 | 3.1% |
| Authorized generics (NDA) | 4 | 2.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dihydropyridine Calcium Channel Blocker | 194 |
| Calcium Channel Blocker | 183 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.